ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

CSPC Pharmaceutical Group Limited clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 355 studies whose lead sponsor is CSPC Pharmaceutical Group Limited or one of 12 companies grouped under it. 170 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 12 registry names, not the registry’s. See them and correct one ↓

Compare CSPC Pharmaceutical Group with Hoffmann-La Roche and Merck →

Pipeline: 68 programs

Each counted once: 65 with a study CSPC Pharmaceutical Group Limited leads registered in the last two years, 3 more from CSPC Pharmaceutical Group Limited's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)
  • Named by CSPC Pharmaceutical Group Limited only (no registered study yet; not in the 68)

The 5 of 25 with the most live studies.

Program
Anti-EGFR Antibody-drug Conjugate CPO301SYS6010Phase 3 · CSPC Pharmaceutical Group Limited: Phase 3 · 15 live · Carcinoma, Non-Small-Cell Lung · primary completion Nov 2026☆ Track
DocetaxelCKD810Phase 3 · 11 live · Breast Neoplasms · primary completion Dec 2026☆ Track
enlonstobartPhase 3 · 10 live · Carcinoma, Non-Small-Cell Lung · primary completion Apr 2027☆ Track
becotatugPhase 3 · CSPC Pharmaceutical Group Limited: Phase 3 · 8 live · Carcinoma, Non-Small-Cell Lung · primary completion Mar 2027☆ Track
anbenitamabKN026Phase 3 · CSPC Pharmaceutical Group Limited: Registration · 6 live · Breast Neoplasms · primary completion Dec 2026☆ Track

20 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of CSPC Pharmaceutical Group Limited’s own registered studies; “CSPC Pharmaceutical Group Limited says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

3 of CSPC Pharmaceutical Group’s programs have a dated deal behind them: 3 brought in. Each from the companies’ own releases and filings, linked; the registry does not record them.

Brought in 3

What it is testing

The drugs CSPC Pharmaceutical Group Limited’s studies test, most open studies first — 90 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 90; every drug is on its own page, and each page lists its sponsors.

Coming up

55 of CSPC Pharmaceutical Group Limited’s studies under way reach primary completion within a year, 10 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 3N’26
  2. 6D
  3. 6J’27
  4. 4F
  5. 4M
  6. 6A
  7. 3M
  8. 3J
  9. 5J
  10. 3A
  11. 6S
  12. 3O
  13. 3N

The 12 nearest

Show 7 more

Add all 55 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

Newly registered14

Show 9 more

All 355 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now17048%Not yet recruiting 97 · Recruiting 72 · Enrolling by invitation 1
  • Under way, not recruiting113%
  • Completed6418%
  • Stopped early185%Terminated 13 · Suspended 3 · Withdrawn 2
  • Status unknown or other9226%

Phase

Where

  • China242
  • Australia2
  • United States2

Over the years

  1. 11
  2. 12
  3. 13
  4. 14
  5. 15
  6. 16
  7. 17
  8. 18
  9. 19
  10. 20
  11. 21
  12. 22
  13. 23
  14. 24
  15. 25
  16. 7426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to CSPC Pharmaceutical Group Limited.

  • CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    167 studies →
  • Shanghai JMT-Bio Inc.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    42 studies →
  • CSPC Megalith Biopharmaceutical Co.,Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    42 studies →
  • CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    30 studies →
  • CSPC Ouyi Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    30 studies →
  • CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    26 studies →
  • InnovStone Therapeutics Limited
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • NovaRock Biotherapeutics, Ltd
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • AlaMab Therapeutics (Shanghai) Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • CSPC-NBP Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
    Acquired — became part of CSPC Pharmaceutical Group Limited, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Guangzhou Recomgen Biotech Co., Ltd.
    Acquired — became part of CSPC Pharmaceutical Group Limited, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions CSPC Pharmaceutical Group Limited leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 355. Browse all 355 →